Read entire article here.

Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has increased its strategic investment in CannaPacific Pty. Limited (“CannaPacific”), a medical cannabis company that is federally licensed to cultivate and research cannabis in Australia.

A West Australian study is investigating the impact of medicinal cannabis on the quality of life and behaviours of aged care residents living with dementia.

The study is being conducted by the Institute of Health Research, which is based at University at Notre Dame Australia’s Fremantle campus, in partnership with Israel-based pharmaceutical company MGC Pharmaceuticals.

Lead researcher Dr Amanda Timler said the study aimed to improve the quality of life of participants and relieve any negative symptoms associated with dementia.

Dr Amanda Timler

Minister for Health Greg Hunt provides an insight into Australia’s experience with legalising medical cannabis, three years on.

In 2018, two years after Australia legalised the growing of cannabis for medical and scientific purposes, Minister for Health Greg Hunt announced that the federal government was to allow the export of medical cannabis products in an effort to secure both long-term supplies for patients and the development of the domestic cannabis industry.

Here, Hunt tells Health Europa more about the decision, outlines the measures that have been put in place to ensure patients can access the medicines they need, and reflects on what other countries can learn from Australia’s experiences with legalisation.

An Australian man caught growing cannabis has managed to evade a jail sentence after a judge determined that his plants were unusable.

On September 19, 2018, police conducted a search at a farm in Balingup, Western Australia where 37-year-old horticulturist, David Giumelli was working.

During the search, officers discovered 39 small cannabis plants, five seedlings, and ten mature plants.

Police also found more than 316 grams of loose cannabis material in a hydroponic shed where some of the plants were growing and 30.2 grams inside the house, reports the Kalgoorlie Miner.

Sydney-based medical cannabis grower and manufacturer THC Global (ASX: THC) is buddding in Asia through a new partnership with Malaysian bio-tech company Heleogenics.

Through the partnership, THC's main goal is to liaise with the Malaysian government and push for its legalisation of medicinal cannabis as well as the development of policy frameworks and legislation.

THC will also work with Heleogenics to explore options in other Asian countries where there may be opportunities to enter fledgling cannabis markets.

Heleogenics has pioneered solutions that accelerate the breeding of new varieties of plants, and THC CEO Ken Charteris says it's a coup to have them on board.

Towpik highlights MediHuanna’s work to educate health professionals about the science of medicinal cannabis and equip them with the practical skills necessary to prescribe and treat those in need.

Tilray, Inc. (NASDAQ:TLRY), a global leader in cannabis research and production, today announced its support of two new clinical studies: a pilot study led by Murdoch Children’s Research Institute (MCRI) in Melbourne, to evaluate the feasibility and acceptability of a larger randomized placebo-controlled trial of cannabis extract as a form of treatment for reducing Severe Behavioral Problems (SBP) in pediatric patients with Intellectual Disabilities (ID); and a study with McGill University Health Centre’s Division of Infectious Diseases and Chronic Viral Illness, to examine the effectiveness of medical cannabis on immune activation in People Living with HIV.

An Australian medical research company is teaming up with a University of Sydney research fund to perform clinical trials to investigate if medical cannabis could be a potential treatment for individuals with Tourette syndrome.

Wesley Medical Research in Brisbane will receive cannabis “facilitation” from University of Sydney’s Lambert Initiative for Cannabinoid Therapeutics with Bod Australia, and the trial is being referred to as the “first of its kind.”

Legalizing the sale of marijuana doesn't lead to an increase in cannabis consumption, but decriminalizing the use and possession of weed does, writes Calvin Hughes and James McClure.